Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer

被引：34
|
作者：
Mao, C. [1 ]
Liao, R-Y [1 ]
Chen, Q. [1 ]
机构：
[1] So Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China
来源：
BRITISH JOURNAL OF CANCER | 2010年 / 102卷 / 05期
关键词：
D O I：
10.1038/sj.bjc.6605575
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：940 / 940
页数：1
相关论文
共 50 条
  • [1] Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
    C Mao
    R-Y Liao
    Q Chen
    British Journal of Cancer, 2010, 102 : 940 - 940
  • [2] PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
    M Frattini
    P Saletti
    E Romagnani
    V Martin
    F Molinari
    M Ghisletta
    A Camponovo
    L L Etienne
    F Cavalli
    L Mazzucchelli
    British Journal of Cancer, 2007, 97 : 1139 - 1145
  • [3] PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
    Frattini, M.
    Saletti, P.
    Romagnani, E.
    Martin, V.
    Molinari, F.
    Ghisletta, M.
    Camponovo, A.
    Etienne, L. L.
    Cavalli, F.
    Mazzucchelli, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1139 - 1145
  • [4] PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
    Sartore-Bianchi, Andrea
    Martini, Miriam
    Molinari, Francesca
    Veronese, Silvio
    Nichelatti, Michele
    Artale, Salvatore
    Di Nicolantonio, Federica
    Saletti, Piercarlo
    De Dosso, Sara
    Mazzucchelli, Luca
    Frattini, Milo
    Siena, Salvatore
    Bardelli, Alberto
    CANCER RESEARCH, 2009, 69 (05) : 1851 - 1857
  • [5] BRAF, PIK3CA, and KRAS mutations and loss of PTEN expression impair response to EGFR-targeted therapies in metastatic colorectal cancer
    Di Nicolantonio, Federica
    Sartore-Bianchi, Andrea
    Molinari, Francesca
    Martini, Miriam
    Saletti, Piercarlo
    Mazzucchelli, Luca
    Veronese, Silvio
    Moroni, Mauro
    Nichelatti, Michele
    Frattini, Milo
    Siena, Salvatore
    Bardelli, Alberto
    CANCER RESEARCH, 2009, 69
  • [6] Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
    Riera, Pau
    Rodriguez-Santiago, Benjamin
    Lasa, Adriana
    Gonzalez-Quereda, Lidia
    Martin, Berta
    Salazar, Juliana
    Sebio, Ana
    Virgili, Anna C.
    Minguillon, Jordi
    Camps, Cristina
    Surralles, Jordi
    Paez, David
    CANCERS, 2020, 12 (08) : 1 - 15
  • [7] Acquired resistance to EGFR-targeted therapies in colorectal cancer
    Van Emburgh, Beth O.
    Sartore-Bianchi, Andrea
    Di Nicolantonio, Federica
    Siena, Salvatore
    Bardelli, Alberto
    MOLECULAR ONCOLOGY, 2014, 8 (06) : 1084 - 1094
  • [8] Novel somatic genetic variants as predictors of resistance to EGFR-targeted therapies in metastatic colorectal cancer patients
    Riera, P.
    Rodriguez-Santiago, B.
    Lasa, A.
    Gonzalez-Quereda, L.
    Martin, B.
    Salazar, J.
    Sebio Garcia, A.
    Virgili Manrique, A. C.
    Surralles, J.
    Paez, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S434 - S434
  • [9] EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.
    Gumus, Mahmut
    Geredeli, Caglayan
    Ucar, Mahmut
    Kaya, Serap
    Demir, Hacer
    Unal, Olcun Umit
    Degirmenci, Mustafa
    Dogu, Gamze Gokoz
    Turan, Nedim
    Yildirim, Nilgun
    Basal, Fatma Bugdayci
    Arpaci, Erkan
    Karaagac, Mustafa
    Harputluoglu, Hakan
    Turk, Had Mehmet
    Dane, Faysal
    Ozkan, Metin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
    Sartore-Bianchi, Andrea
    Amatu, Alessio
    Porcu, Luca
    Ghezzi, Silvia
    Lonardi, Sara
    Leone, Francesco
    Bergamo, Francesca
    Fenocchio, Elisabetta
    Martinelli, Erika
    Borelli, Beatrice
    Tosi, Federica
    Racca, Patrizia
    Valtorta, Emanuele
    Bonoldi, Emanuela
    Martino, Cosimo
    Vaghi, Caterina
    Marrapese, Giovanna
    Ciardiello, Fortunato
    Zagonel, Vittorina
    Bardelli, Alberto
    Trusolino, Livio
    Torri, Valter
    Marsoni, Silvia
    Siena, Salvatore
    ONCOLOGIST, 2019, 24 (10): : 1395 - 1402
12345